
PharmaCielo (OTCQX:PCLOF) will start supplying the German market with three THC-dominant products, with commercial shipments expected to begin in late 2022.
This is PharmaCielo's first sales agreement related to THC products. It represents a significant milestone related to management's re-focusing of PharmaCielo's product strategy toward THC-dominant products.